COVID-19 Impact on Global Subdermal Contraceptive Implant Market Insights, Forecast to 2026

Publisher Name :
Date: 14-May-2020
No. of pages: 117
Inquire Before Buying

Subdermal Contraceptive Implant market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Subdermal Contraceptive Implant market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Subdermal Contraceptive Implant market is segmented into

- Etonogestrel Implant

- Levonorgestrel Implant

- Other

Segment by Application, the Subdermal Contraceptive Implant market is segmented into

- Hospital

- Clinic

Regional and Country-level AnalysisThe Subdermal Contraceptive Implant market is analysed and market size information is provided by regions (countries).

The key regions covered in the Subdermal Contraceptive Implant market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Subdermal Contraceptive Implant Market Share Analysis

Subdermal Contraceptive Implant market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Subdermal Contraceptive Implant business, the date to enter into the Subdermal Contraceptive Implant market, Subdermal Contraceptive Implant product introduction, recent developments, etc.

The major vendors covered:

- Bayer

- Merck & Co. Inc.

- Shanghai Dahua Pharmaceutical

- ...

COVID-19 Impact on Global Subdermal Contraceptive Implant Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Subdermal Contraceptive Implant Product Introduction
1.2 Market Segments
1.3 Key Subdermal Contraceptive Implant Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Subdermal Contraceptive Implant Market Size Growth Rate by Type
1.4.2 Etonogestrel Implant
1.4.3 Levonorgestrel Implant
1.4.4 Other
1.5 Market by Application
1.5.1 Global Subdermal Contraceptive Implant Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.6 Coronavirus Disease 2019 (Covid-19): Subdermal Contraceptive Implant Industry Impact
1.6.1 How the Covid-19 is Affecting the Subdermal Contraceptive Implant Industry
1.6.1.1 Subdermal Contraceptive Implant Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Subdermal Contraceptive Implant Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Subdermal Contraceptive Implant Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Subdermal Contraceptive Implant Market Size Estimates and Forecasts
2.1.1 Global Subdermal Contraceptive Implant Revenue 2015-2026
2.1.2 Global Subdermal Contraceptive Implant Sales 2015-2026
2.2 Subdermal Contraceptive Implant Market Size by Region: 2020 Versus 2026
2.2.1 Global Subdermal Contraceptive Implant Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Subdermal Contraceptive Implant Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Subdermal Contraceptive Implant Competitor Landscape by Players
3.1 Subdermal Contraceptive Implant Sales by Manufacturers
3.1.1 Subdermal Contraceptive Implant Sales by Manufacturers (2015-2020)
3.1.2 Subdermal Contraceptive Implant Sales Market Share by Manufacturers (2015-2020)
3.2 Subdermal Contraceptive Implant Revenue by Manufacturers
3.2.1 Subdermal Contraceptive Implant Revenue by Manufacturers (2015-2020)
3.2.2 Subdermal Contraceptive Implant Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Subdermal Contraceptive Implant Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Subdermal Contraceptive Implant Revenue in 2019
3.2.5 Global Subdermal Contraceptive Implant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Subdermal Contraceptive Implant Price by Manufacturers
3.4 Subdermal Contraceptive Implant Manufacturing Base Distribution, Product Types
3.4.1 Subdermal Contraceptive Implant Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Subdermal Contraceptive Implant Product Type
3.4.3 Date of International Manufacturers Enter into Subdermal Contraceptive Implant Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Subdermal Contraceptive Implant Market Size by Type (2015-2020)
4.1.1 Global Subdermal Contraceptive Implant Sales by Type (2015-2020)
4.1.2 Global Subdermal Contraceptive Implant Revenue by Type (2015-2020)
4.1.3 Subdermal Contraceptive Implant Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Subdermal Contraceptive Implant Market Size Forecast by Type (2021-2026)
4.2.1 Global Subdermal Contraceptive Implant Sales Forecast by Type (2021-2026)
4.2.2 Global Subdermal Contraceptive Implant Revenue Forecast by Type (2021-2026)
4.2.3 Subdermal Contraceptive Implant Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Subdermal Contraceptive Implant Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Subdermal Contraceptive Implant Market Size by Application (2015-2020)
5.1.1 Global Subdermal Contraceptive Implant Sales by Application (2015-2020)
5.1.2 Global Subdermal Contraceptive Implant Revenue by Application (2015-2020)
5.1.3 Subdermal Contraceptive Implant Price by Application (2015-2020)
5.2 Subdermal Contraceptive Implant Market Size Forecast by Application (2021-2026)
5.2.1 Global Subdermal Contraceptive Implant Sales Forecast by Application (2021-2026)
5.2.2 Global Subdermal Contraceptive Implant Revenue Forecast by Application (2021-2026)
5.2.3 Global Subdermal Contraceptive Implant Price Forecast by Application (2021-2026)
6 North America
6.1 North America Subdermal Contraceptive Implant by Country
6.1.1 North America Subdermal Contraceptive Implant Sales by Country
6.1.2 North America Subdermal Contraceptive Implant Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Subdermal Contraceptive Implant Market Facts & Figures by Type
6.3 North America Subdermal Contraceptive Implant Market Facts & Figures by Application
7 Europe
7.1 Europe Subdermal Contraceptive Implant by Country
7.1.1 Europe Subdermal Contraceptive Implant Sales by Country
7.1.2 Europe Subdermal Contraceptive Implant Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Subdermal Contraceptive Implant Market Facts & Figures by Type
7.3 Europe Subdermal Contraceptive Implant Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Subdermal Contraceptive Implant by Region
8.1.1 Asia Pacific Subdermal Contraceptive Implant Sales by Region
8.1.2 Asia Pacific Subdermal Contraceptive Implant Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Subdermal Contraceptive Implant Market Facts & Figures by Type
8.3 Asia Pacific Subdermal Contraceptive Implant Market Facts & Figures by Application
9 Latin America
9.1 Latin America Subdermal Contraceptive Implant by Country
9.1.1 Latin America Subdermal Contraceptive Implant Sales by Country
9.1.2 Latin America Subdermal Contraceptive Implant Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Subdermal Contraceptive Implant Market Facts & Figures by Type
9.3 Central & South America Subdermal Contraceptive Implant Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Subdermal Contraceptive Implant by Country
10.1.1 Middle East and Africa Subdermal Contraceptive Implant Sales by Country
10.1.2 Middle East and Africa Subdermal Contraceptive Implant Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Subdermal Contraceptive Implant Market Facts & Figures by Type
10.3 Middle East and Africa Subdermal Contraceptive Implant Market Facts & Figures by Application
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description, Business Overview and Total Revenue
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Subdermal Contraceptive Implant Products Offered
11.1.5 Bayer Recent Development
11.2 Merck & Co. Inc.
11.2.1 Merck & Co. Inc. Corporation Information
11.2.2 Merck & Co. Inc. Description, Business Overview and Total Revenue
11.2.3 Merck & Co. Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck & Co. Inc. Subdermal Contraceptive Implant Products Offered
11.2.5 Merck & Co. Inc. Recent Development
11.3 Shanghai Dahua Pharmaceutical
11.3.1 Shanghai Dahua Pharmaceutical Corporation Information
11.3.2 Shanghai Dahua Pharmaceutical Description, Business Overview and Total Revenue
11.3.3 Shanghai Dahua Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Shanghai Dahua Pharmaceutical Subdermal Contraceptive Implant Products Offered
11.3.5 Shanghai Dahua Pharmaceutical Recent Development
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description, Business Overview and Total Revenue
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Subdermal Contraceptive Implant Products Offered
11.1.5 Bayer Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Subdermal Contraceptive Implant Market Estimates and Projections by Region
12.1.1 Global Subdermal Contraceptive Implant Sales Forecast by Regions 2021-2026
12.1.2 Global Subdermal Contraceptive Implant Revenue Forecast by Regions 2021-2026
12.2 North America Subdermal Contraceptive Implant Market Size Forecast (2021-2026)
12.2.1 North America: Subdermal Contraceptive Implant Sales Forecast (2021-2026)
12.2.2 North America: Subdermal Contraceptive Implant Revenue Forecast (2021-2026)
12.2.3 North America: Subdermal Contraceptive Implant Market Size Forecast by Country (2021-2026)
12.3 Europe Subdermal Contraceptive Implant Market Size Forecast (2021-2026)
12.3.1 Europe: Subdermal Contraceptive Implant Sales Forecast (2021-2026)
12.3.2 Europe: Subdermal Contraceptive Implant Revenue Forecast (2021-2026)
12.3.3 Europe: Subdermal Contraceptive Implant Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Subdermal Contraceptive Implant Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Subdermal Contraceptive Implant Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Subdermal Contraceptive Implant Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Subdermal Contraceptive Implant Market Size Forecast by Region (2021-2026)
12.5 Latin America Subdermal Contraceptive Implant Market Size Forecast (2021-2026)
12.5.1 Latin America: Subdermal Contraceptive Implant Sales Forecast (2021-2026)
12.5.2 Latin America: Subdermal Contraceptive Implant Revenue Forecast (2021-2026)
12.5.3 Latin America: Subdermal Contraceptive Implant Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Subdermal Contraceptive Implant Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Subdermal Contraceptive Implant Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Subdermal Contraceptive Implant Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Subdermal Contraceptive Implant Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Subdermal Contraceptive Implant Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Subdermal Contraceptive Implant Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Subdermal Contraceptive Implant Market Segments
Table 2. Ranking of Global Top Subdermal Contraceptive Implant Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Subdermal Contraceptive Implant Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Etonogestrel Implant
Table 5. Major Manufacturers of Levonorgestrel Implant
Table 6. Major Manufacturers of Other
Table 7. COVID-19 Impact Global Market: (Four Subdermal Contraceptive Implant Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Subdermal Contraceptive Implant Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Subdermal Contraceptive Implant Players to Combat Covid-19 Impact
Table 12. Global Subdermal Contraceptive Implant Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Subdermal Contraceptive Implant Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global Subdermal Contraceptive Implant Sales by Regions 2015-2020 (K Units)
Table 15. Global Subdermal Contraceptive Implant Sales Market Share by Regions (2015-2020)
Table 16. Global Subdermal Contraceptive Implant Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Subdermal Contraceptive Implant Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Subdermal Contraceptive Implant Sales Share by Manufacturers (2015-2020)
Table 19. Global Subdermal Contraceptive Implant Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Subdermal Contraceptive Implant by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Subdermal Contraceptive Implant as of 2019)
Table 21. Subdermal Contraceptive Implant Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Subdermal Contraceptive Implant Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Subdermal Contraceptive Implant Price (2015-2020) (US$/Unit)
Table 24. Subdermal Contraceptive Implant Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Subdermal Contraceptive Implant Product Type
Table 26. Date of International Manufacturers Enter into Subdermal Contraceptive Implant Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Subdermal Contraceptive Implant Sales by Type (2015-2020) (K Units)
Table 29. Global Subdermal Contraceptive Implant Sales Share by Type (2015-2020)
Table 30. Global Subdermal Contraceptive Implant Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Subdermal Contraceptive Implant Revenue Share by Type (2015-2020)
Table 32. Subdermal Contraceptive Implant Average Selling Price (ASP) by Type 2015-2020 (US$/Unit)
Table 33. Global Subdermal Contraceptive Implant Sales by Application (2015-2020) (K Units)
Table 34. Global Subdermal Contraceptive Implant Sales Share by Application (2015-2020)
Table 35. North America Subdermal Contraceptive Implant Sales by Country (2015-2020) (K Units)
Table 36. North America Subdermal Contraceptive Implant Sales Market Share by Country (2015-2020)
Table 37. North America Subdermal Contraceptive Implant Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Subdermal Contraceptive Implant Revenue Market Share by Country (2015-2020)
Table 39. North America Subdermal Contraceptive Implant Sales by Type (2015-2020) (K Units)
Table 40. North America Subdermal Contraceptive Implant Sales Market Share by Type (2015-2020)
Table 41. North America Subdermal Contraceptive Implant Sales by Application (2015-2020) (K Units)
Table 42. North America Subdermal Contraceptive Implant Sales Market Share by Application (2015-2020)
Table 43. Europe Subdermal Contraceptive Implant Sales by Country (2015-2020) (K Units)
Table 44. Europe Subdermal Contraceptive Implant Sales Market Share by Country (2015-2020)
Table 45. Europe Subdermal Contraceptive Implant Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Subdermal Contraceptive Implant Revenue Market Share by Country (2015-2020)
Table 47. Europe Subdermal Contraceptive Implant Sales by Type (2015-2020) (K Units)
Table 48. Europe Subdermal Contraceptive Implant Sales Market Share by Type (2015-2020)
Table 49. Europe Subdermal Contraceptive Implant Sales by Application (2015-2020) (K Units)
Table 50. Europe Subdermal Contraceptive Implant Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Subdermal Contraceptive Implant Sales by Region (2015-2020) (K Units)
Table 52. Asia Pacific Subdermal Contraceptive Implant Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Subdermal Contraceptive Implant Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Subdermal Contraceptive Implant Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Subdermal Contraceptive Implant Sales by Type (2015-2020) (K Units)
Table 56. Asia Pacific Subdermal Contraceptive Implant Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Subdermal Contraceptive Implant Sales by Application (2015-2020) (K Units)
Table 58. Asia Pacific Subdermal Contraceptive Implant Sales Market Share by Application (2015-2020)
Table 59. Latin America Subdermal Contraceptive Implant Sales by Country (2015-2020) (K Units)
Table 60. Latin America Subdermal Contraceptive Implant Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Subdermal Contraceptive Implant Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Subdermal Contraceptive Implant Revenue Market Share by Country (2015-2020)
Table 63. Latin America Subdermal Contraceptive Implant Sales by Type (2015-2020) (K Units)
Table 64. Latin America Subdermal Contraceptive Implant Sales Market Share by Type (2015-2020)
Table 65. Latin America Subdermal Contraceptive Implant Sales by Application (2015-2020) (K Units)
Table 66. Latin America Subdermal Contraceptive Implant Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Subdermal Contraceptive Implant Sales by Country (2015-2020) (K Units)
Table 68. Middle East and Africa Subdermal Contraceptive Implant Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Subdermal Contraceptive Implant Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Subdermal Contraceptive Implant Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Subdermal Contraceptive Implant Sales by Type (2015-2020) (K Units)
Table 72. Middle East and Africa Subdermal Contraceptive Implant Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Subdermal Contraceptive Implant Sales by Application (2015-2020) (K Units)
Table 74. Middle East and Africa Subdermal Contraceptive Implant Sales Market Share by Application (2015-2020)
Table 75. Bayer Corporation Information
Table 76. Bayer Description and Major Businesses
Table 77. Bayer Subdermal Contraceptive Implant Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 78. Bayer Product
Table 79. Bayer Recent Development
Table 80. Merck & Co. Inc. Corporation Information
Table 81. Merck & Co. Inc. Description and Major Businesses
Table 82. Merck & Co. Inc. Subdermal Contraceptive Implant Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 83. Merck & Co. Inc. Product
Table 84. Merck & Co. Inc. Recent Development
Table 85. Shanghai Dahua Pharmaceutical Corporation Information
Table 86. Shanghai Dahua Pharmaceutical Description and Major Businesses
Table 87. Shanghai Dahua Pharmaceutical Subdermal Contraceptive Implant Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 88. Shanghai Dahua Pharmaceutical Product
Table 89. Shanghai Dahua Pharmaceutical Recent Development
Table 90. Global Subdermal Contraceptive Implant Sales Forecast by Regions (2021-2026) (K Units)
Table 91. Global Subdermal Contraceptive Implant Sales Market Share Forecast by Regions (2021-2026)
Table 92. Global Subdermal Contraceptive Implant Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 93. Global Subdermal Contraceptive Implant Revenue Market Share Forecast by Regions (2021-2026)
Table 94. North America: Subdermal Contraceptive Implant Sales Forecast by Country (2021-2026) (K Units)
Table 95. North America: Subdermal Contraceptive Implant Revenue Forecast by Country (2021-2026) (US$ Million)
Table 96. Europe: Subdermal Contraceptive Implant Sales Forecast by Country (2021-2026) (K Units)
Table 97. Europe: Subdermal Contraceptive Implant Revenue Forecast by Country (2021-2026) (US$ Million)
Table 98. Asia Pacific: Subdermal Contraceptive Implant Sales Forecast by Region (2021-2026) (K Units)
Table 99. Asia Pacific: Subdermal Contraceptive Implant Revenue Forecast by Region (2021-2026) (US$ Million)
Table 100. Latin America: Subdermal Contraceptive Implant Sales Forecast by Country (2021-2026) (K Units)
Table 101. Latin America: Subdermal Contraceptive Implant Revenue Forecast by Country (2021-2026) (US$ Million)
Table 102. Middle East and Africa: Subdermal Contraceptive Implant Sales Forecast by Country (2021-2026) (K Units)
Table 103. Middle East and Africa: Subdermal Contraceptive Implant Revenue Forecast by Country (2021-2026) (US$ Million)
Table 104. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 105. Key Challenges
Table 106. Market Risks
Table 107. Main Points Interviewed from Key Subdermal Contraceptive Implant Players
Table 108. Subdermal Contraceptive Implant Customers List
Table 109. Subdermal Contraceptive Implant Distributors List
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Subdermal Contraceptive Implant Product Picture
Figure 2. Global Subdermal Contraceptive Implant Sales Market Share by Type in 2020 & 2026
Figure 3. Etonogestrel Implant Product Picture
Figure 4. Levonorgestrel Implant Product Picture
Figure 5. Other Product Picture
Figure 6. Global Subdermal Contraceptive Implant Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Subdermal Contraceptive Implant Report Years Considered
Figure 10. Global Subdermal Contraceptive Implant Market Size 2015-2026 (US$ Million)
Figure 11. Global Subdermal Contraceptive Implant Sales 2015-2026 (K Units)
Figure 12. Global Subdermal Contraceptive Implant Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Subdermal Contraceptive Implant Sales Market Share by Region (2015-2020)
Figure 14. Global Subdermal Contraceptive Implant Sales Market Share by Region in 2019
Figure 15. Global Subdermal Contraceptive Implant Revenue Market Share by Region (2015-2020)
Figure 16. Global Subdermal Contraceptive Implant Revenue Market Share by Region in 2019
Figure 17. Global Subdermal Contraceptive Implant Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Subdermal Contraceptive Implant Revenue in 2019
Figure 19. Subdermal Contraceptive Implant Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Subdermal Contraceptive Implant Sales Market Share by Type (2015-2020)
Figure 21. Global Subdermal Contraceptive Implant Sales Market Share by Type in 2019
Figure 22. Global Subdermal Contraceptive Implant Revenue Market Share by Type (2015-2020)
Figure 23. Global Subdermal Contraceptive Implant Revenue Market Share by Type in 2019
Figure 24. Global Subdermal Contraceptive Implant Market Share by Price Range (2015-2020)
Figure 25. Global Subdermal Contraceptive Implant Sales Market Share by Application (2015-2020)
Figure 26. Global Subdermal Contraceptive Implant Sales Market Share by Application in 2019
Figure 27. Global Subdermal Contraceptive Implant Revenue Market Share by Application (2015-2020)
Figure 28. Global Subdermal Contraceptive Implant Revenue Market Share by Application in 2019
Figure 29. North America Subdermal Contraceptive Implant Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Subdermal Contraceptive Implant Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Subdermal Contraceptive Implant Sales Market Share by Country in 2019
Figure 32. North America Subdermal Contraceptive Implant Revenue Market Share by Country in 2019
Figure 33. U.S. Subdermal Contraceptive Implant Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Subdermal Contraceptive Implant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Subdermal Contraceptive Implant Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Subdermal Contraceptive Implant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Subdermal Contraceptive Implant Market Share by Type in 2019
Figure 38. North America Subdermal Contraceptive Implant Market Share by Application in 2019
Figure 39. Europe Subdermal Contraceptive Implant Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Subdermal Contraceptive Implant Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Subdermal Contraceptive Implant Sales Market Share by Country in 2019
Figure 42. Europe Subdermal Contraceptive Implant Revenue Market Share by Country in 2019
Figure 43. Germany Subdermal Contraceptive Implant Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Subdermal Contraceptive Implant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Subdermal Contraceptive Implant Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Subdermal Contraceptive Implant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Subdermal Contraceptive Implant Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Subdermal Contraceptive Implant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Subdermal Contraceptive Implant Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Subdermal Contraceptive Implant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Subdermal Contraceptive Implant Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Subdermal Contraceptive Implant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Subdermal Contraceptive Implant Market Share by Type in 2019
Figure 54. Europe Subdermal Contraceptive Implant Market Share by Application in 2019
Figure 55. Asia Pacific Subdermal Contraceptive Implant Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Subdermal Contraceptive Implant Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Subdermal Contraceptive Implant Sales Market Share by Region in 2019
Figure 58. Asia Pacific Subdermal Contraceptive Implant Revenue Market Share by Region in 2019
Figure 59. China Subdermal Contraceptive Implant Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Subdermal Contraceptive Implant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Subdermal Contraceptive Implant Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Subdermal Contraceptive Implant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Subdermal Contraceptive Implant Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Subdermal Contraceptive Implant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Subdermal Contraceptive Implant Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Subdermal Contraceptive Implant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Subdermal Contraceptive Implant Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Subdermal Contraceptive Implant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Subdermal Contraceptive Implant Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Subdermal Contraceptive Implant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Subdermal Contraceptive Implant Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Subdermal Contraceptive Implant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Subdermal Contraceptive Implant Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Subdermal Contraceptive Implant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Subdermal Contraceptive Implant Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Subdermal Contraceptive Implant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Subdermal Contraceptive Implant Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Subdermal Contraceptive Implant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Subdermal Contraceptive Implant Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Subdermal Contraceptive Implant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Subdermal Contraceptive Implant Market Share by Type in 2019
Figure 82. Asia Pacific Subdermal Contraceptive Implant Market Share by Application in 2019
Figure 83. Latin America Subdermal Contraceptive Implant Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Subdermal Contraceptive Implant Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Subdermal Contraceptive Implant Sales Market Share by Country in 2019
Figure 86. Latin America Subdermal Contraceptive Implant Revenue Market Share by Country in 2019
Figure 87. Mexico Subdermal Contraceptive Implant Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Subdermal Contraceptive Implant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Subdermal Contraceptive Implant Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Subdermal Contraceptive Implant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Subdermal Contraceptive Implant Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Subdermal Contraceptive Implant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Subdermal Contraceptive Implant Market Share by Type in 2019
Figure 94. Latin America Subdermal Contraceptive Implant Market Share by Application in 2019
Figure 95. Middle East and Africa Subdermal Contraceptive Implant Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Subdermal Contraceptive Implant Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Subdermal Contraceptive Implant Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Subdermal Contraceptive Implant Revenue Market Share by Country in 2019
Figure 99. Turkey Subdermal Contraceptive Implant Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Subdermal Contraceptive Implant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Subdermal Contraceptive Implant Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Subdermal Contraceptive Implant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Subdermal Contraceptive Implant Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Subdermal Contraceptive Implant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Subdermal Contraceptive Implant Market Share by Type in 2019
Figure 106. Middle East and Africa Subdermal Contraceptive Implant Market Share by Application in 2019
Figure 107. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Merck & Co. Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Shanghai Dahua Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. North America Subdermal Contraceptive Implant Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. North America Subdermal Contraceptive Implant Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Subdermal Contraceptive Implant Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Europe Subdermal Contraceptive Implant Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Subdermal Contraceptive Implant Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Asia Pacific Subdermal Contraceptive Implant Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Subdermal Contraceptive Implant Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Latin America Subdermal Contraceptive Implant Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Subdermal Contraceptive Implant Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Middle East and Africa Subdermal Contraceptive Implant Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs